Clinical Trials in Medicine Hat, Alberta
5 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
Ischemic Stroke; Ischemic Attack, Transient
Janssen Research & Development, LLC15,000 enrolled880 locationsNCT05702034
Recruiting
Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
Atrial FibrillationStroke
Population Health Research Institute2,270 enrolled105 locationsNCT03968393
Recruiting
Phase 3
ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
Stroke, AcuteAcute Ischemic Stroke AISStroke, Acute, Stroke Ischemic
University of Calgary4,000 enrolled24 locationsNCT06320431
Recruiting
Not Applicable
Alberta Collaborative QI Strategies to Improve Outcomes of Moderate and Late Preterm Infants (ABC-QI Trial)
Length of Stay
University of Calgary9,500 enrolled12 locationsNCT05231200
Recruiting
Not Applicable
Optimizing the Management of Staphylococcus Aureus Bacteremia (OPTIMUS-SAB)
Staph Aureus Bacteremia
University of Alberta1,800 enrolled101 locationsNCT06338176